ArticleActa pharmaceutica Sinica. B2022

Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis.

Heng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.